R. Ferraccioli, A. Forni
FULL PAPER
25 °C): δ = 2.43 (s, 3 H), 2.70 (dd, J = 14.7, 4.2 Hz, 1 H), 2.90 (dd,
J = 14.7, 8.7 Hz, 1 H), 3.43 (s, 3 H), 3.75 (d, J = 18.9 Hz, 1 H),
3.95 (d, J = 18.9 Hz, 1 H), 5.56 (dd, J = 8.7, 4.2 Hz, 1 H), 7.11–
7.49 (m, 8 H) ppm. 13C NMR (75 MHz, CDCl3, 25 °C): δ = 18.6,
38.3, 39.5, 51.7, 60.1, 125.7, 127.3, 128.2, 129.0, 129.2, 132.5, 132.8,
fect of water as co-solvent, which led to the development
of conditions for successfully performing the reaction.
Experimental Section
133.4, 141.5, 169.1, 170.2 ppm. IR (neat): ν = 2951, 2924, 2852,
˜
1733, 1667, 1599 cm–1. HRMS (ESI): m/z [M + Na]+ calcd. for
General: The palladium-catalysed reactions were performed under
nitrogen using standard Schlenk and vacuum line techniques. 1H
and 13C NMR spectra were recorded at room temperature in
CDCl3 with a 300-AMX spectrometer at 300 and 75 MHz, respec-
tively. Chemical shifts are reported in ppm. High-resolution mass
spectra were obtained with an FT-ICR mass spectrometer. Infrared
spectra were recorded with an FT-IR spectrophotometer. Melting
points are uncorrected.
C19H19NNaO3: 332.12571; found 332.12547.
rac-Methyl [8-Methyl-3-oxo-2-(1-phenylethyl)-1,2,3,4-tetrahydroiso-
quinolin-1-yl]acetate [5, R1 = Me; R2 = R3 = H; R4 = (rac) α-Meth-
ylbenzyl; R5 = CO2Me, major diastereomer]: 41 mg, 73%; pale yel-
1
low, viscous oil. H NMR (300 MHz, CDCl3, 25 °C): δ = 1.72 (d,
J = 7.5 Hz, 3 H), 1.74 (s, 3 H), 2.71 (dd, J = 15.0, 7.5 Hz, 1 H),
2.87 (d, J = 15.0, 5.1 Hz, 1 H), 3.64 (s, 3 H), 3.64–3.84 (m, 2 H),
4.87 (dd, J = 7.5, 5.1 Hz, 1 H), 6.04 (quartet, J = 7.5 Hz, 1 H),
6.90–7.29 (m, 8 H) ppm. 13C NMR (75 MHz, CDCl3, 25 °C): δ =
16.9, 17.8, 39.0, 41.1, 50.4, 51.7, 51.8, 125.4, 127.3, 127.4, 127.6,
General Procedure for the Synthesis of Tetrahydroisoquinolin-3-ones
(5) and 1,4-Dihydro-1,4-ethanoisoquinolin-3(2H)-ones (6):
A
Schlenk-type flask was charged under nitrogen with Cs2CO3
(108.0 mg, 0.33 mmol), Pd(OAc)2 (3.6 mg, 0.0165 mmol), TFP
(7.7 mg, 0.033 mmol) and norbornene (34.0 mg, 0.36 mmol) in
DMF (1.0 mL). The mixture was stirred at room temp. for 10 min
128.4, 128.5, 132.5, 135.8, 139.7, 170.3, 170.9 ppm. IR (neat): ν =
˜
2950, 1734, 1656, 1538 cm–1. HRMS (ESI): m/z. [M + Na]+ calcd.
for C21H23NNaO3: 360.15701; found 360.15744.
and then treated with
2 (0.33 mmol), 1 (0.165 mmol), 3
Methyl [2-Allyl-8-methyl-3-oxo-1,2,3,4-tetrahydroisoquinolin-1-yl]-
acetate (5, R1 = Me; R2 = R3 = H; R4 = Allyl; R5 = CO2Me):
14 mg, 32%; colourless oil. H NMR (CDCl3, 25 °C): δ = 2.35 (s,
3 H), 2.62 (dd, J = 15.0, 4.2 Hz, 1 H), 2.79 (dd, J = 15.0, 8.7 Hz,
1 H), 3.58–3.8 (m, 3 H overlapped with a singlet at δ = 3.74 ), 3.74
(s, 3 H), 4.79–4.86 (m, 1 H), 5.10–5.18 (m, 3 H), 5.68–5.80 (m, 1
H), 7.04–7.23 (m, 3 H) ppm. 13C NMR (75 MHz, CDCl3, 25 °C):
δ = 18.5, 37.9, 39.2, 48.1, 52.1, 54.5, 117.3, 125.6, 127.9, 128.9,
(0.33 mmol), DMF (1.97 mL) and water (0.33 mL). The homogen-
eous solution was heated at 80 °C whilst stirring for the time re-
ported (Table 2 and Table 3) and then cooled to room temp. Satu-
rated aqueous nBu4NCl (40 mL) was added, the mixture was ex-
tracted with AcOEt (2 ϫ 20 mL), the combined organic phases
were dried (Na2SO4), and the solvent was evaporated under vac-
uum. The residue was purified by flash chromatography on silica
1
gel (eluent: hexane/AcOEt). The isolated 6 [31 mg, 55%, R4
=
132.5, 132.6, 132.8, 134.2, 169.6, 171.1 ppm. IR (neat): ν = 2947,
˜
PMB; 29.5 mg, 61%, R4 = Ph; 28 mg, 53%, R4 = (rac)-α-meth-
ylbenzyl] turned out to be mixtures of diastereomers (by NMR
analysis). In the case of R4 = PMB or Ph, the major one (6a) could
be isolated as a diastereomerically pure compound by crystallisa-
tion (AcOEt).
2926, 1735, 1659, 1599 cm–1. HRMS (ESI): m/z [M + Na]+ calcd.
for C16H19NNaO3: 296.12571; found 296.12587.
Methyl [8-Methoxy-2-(4-methoxybenzyl)-3-oxo-1,2,3,4-tetrahydro-
isoquinolin-1-yl]acetate (5, R1 = MeO; R2 = R3 = H; R4 = PMB; R5
1
= CO2Me): 38 mg, 62%; yellow, viscous oil. H NMR (300 MHz,
Methyl (8-Methyl-3-oxo-1,2,3,4-tetrahydroisoquinolin-1-yl)acetate
CDCl3, 25 °C): δ = 2.69 (dd, J = 14.4, 5.6 Hz, 1 H), 2.78 (dd, J =
14.5, 5.6 Hz, 1 H), 3.65 (s, 3 H), 3.67 (d, J = 19.0 Hz, 1 H), 3.76–
3.82 (m, 1 H), 3.77 (s, 3 H), 3.79 (s, 3 H), 4.20 (d, J = 14.7 Hz, 1
H), 5.18 (t, J = 5.6 Hz, 1 H), 5.32 (d, J = 14.7 Hz, 1 H), 6.73–6.85
(m, 4 H), 7.19–7.30 (m, 3 H) ppm. 13C NMR (75 MHz, CDCl3,
25 °C): δ = 37.0, 38.6, 47.8, 51.7, 52.4, 55.2, 55.4, 108.3, 113.9,
119.6, 123.1, 128.8, 129.2, 133.8, 154.4, 158.9, 169.4, 170.9 ppm.
3
(5, R1 = Me; R2 = R = R4 = H; R5 = CO2Me): 18 mg, 46% as a
white solid, m.p. 140–141 °C (AcOEt). 1H NMR (300 MHz,
CDCl3, 25 °C): δ = 2.35 (s, 3 H), 2.60–2.73 (m, 2 H), 3.57 (d, J =
19.5 Hz, 1 H), 3.65 (d, J = 19.5 Hz, 1 H), 3.79 (s, 3 H), 5.04 (m, 1
H), 6.06 (br. s, 1 H), 7.05 (d, J = 7.4 Hz, 1 H), 7.12 (d, J = 7.2 Hz,
1 H), 7.23 (t, J = 7.5 Hz, 1 H) ppm. 13C NMR (75 MHz, CDCl3,
25 °C): δ = 18.6, 36.5, 40.3, 50.3, 52.1, 126.2, 128.1, 129.1, 131.9,
IR (neat): ν = 2951, 2838, 1735, 1650, 1600, 1513 cm–1. HRMS
˜
(ESI): m/z [M + Na]+ calcd. for C21H23NNaO5: 392.14684; found
133.2, 171.1, 171.3 ppm. IR (nujol): ν = 3182, 2926, 1731, 1676
˜
cm–1. HRMS (ESI): m/z [M + Na]+ calcd. for C13H15NNaO3:
392.14769.
256.09441; found 256.09472.
Methyl [2-(4-Methoxybenzyl)-3-oxo-1,2,3,4-tetrahydrobenzo[h]iso-
quinolin-1-yl]acetate (5, R1 = R2 = benzo; R3 = H; R4 = PMB; R5
= CO2Me): 41 mg, 64%; colourless, viscous oil. 1H NMR (CDCl3,
25 °C): δ = 2.72 (dd, J = 15.3, 4.6 Hz, 1 H), 2.84 (dd, J = 15.3,
7.3 Hz, 1 H), 3.63 (s, 3 H), 3.72 (s, 3 H), 3.8 (d, J = 19.5 Hz, 1 H),
3.9 (d, J = 19.5 Hz, 1 H), 4.15 (d, J = 14.9 Hz, 1 H), 5.45 (d, J =
14.9 Hz, 1 H), 5.68 (dd, J = 7.3, 4.6 Hz, 1 H), 6.75 (d, J = 8.7 Hz,
2 H), 7.18 (d, J = 8.6 Hz, 2 H), 7.27 (m, 1 H), 7.43–7.51 (m, 2 H),
7.70–7.85 (m, 3 H) ppm. 13C NMR (75 MHz, CDCl3, 25 °C): δ =
37.7, 40.0, 48.1, 52.1, 53.6, 55.2, 114.1, 121.7, 125.6, 125.7, 127.1,
128.3, 128.6, 128.8, 129.0, 129.2, 130.0, 130.2, 132.6 ppm. IR (nu-
Methyl [2-(4-Methoxybenzyl)-8-methyl-3-oxo-1,2,3,4-tetrahydroiso-
quinolin-1-yl]acetate (5, R1 = Me; R2 = R3 = H; R4 = PMB; R5 =
CO2Me): 44 mg, 76%; pale yellow, viscous oil. 1H NMR
(300 MHz, CDCl3, 25 °C): δ = 2.04 (s, 3 H), 2.52 (dd, J = 15.3,
4.5 Hz, 1 H), 2.73 (dd, J = 15.3, 9.0 Hz, 1 H), 3.59–3.76 (m, 2 H
overlapped with two singlets at δ = 3.68 and 3.74), 3.68 (s, 3 H),
3.74 (s, 3 H), 3.98 (d, J = 12.0 Hz, 1 H), 5.04 (dd, J = 4.5, 9.0 Hz,
1 H), 5.42 (d, J = 12.0 Hz, 1 H), 6.77 (d, J = 8.7 Hz, 2 H), 6.99 (t,
J = 6.9 Hz, 2 H), 7.07–7.15 (m, 3 H) ppm. 13C NMR (75 MHz,
CDCl3, 25 °C): δ = 18.3, 38.0, 39.0, 48.0, 52.1, 53.6, 55.2, 114.0,
125.5, 127.8, 128.7, 128.7, 129.3, 132.4, 132.5, 134.3, 159.0, 169.8,
jol): ν = 1732, 1651, 1513 cm–1. HRMS (ESI): m/z [M + Na]+ calcd.
˜
171.2 ppm. IR (neat): ν = 2994, 2952, 2838, 1733, 1658, 1513 cm–1.
˜
for C24H23NNaO4: 412.15193; found 412.15187.
HRMS (ESI): m/z [M + Na]+ calcd. for C21H23NNaO4: 376.15193;
Methyl [2-(4-Methoxybenzyl)-6,8-dimethyl-3-oxo-1,2,3,4-tetrahydro-
isoquinolin-1-yl]acetate (5, R1 = R3 = Me; R2 = H; R4 = PMB; R5 =
found 376.15228.
Methyl (8-Methyl-3-oxo-2-phenyl-1,2,3,4-tetrahydroisoquinolin-1- CO2Me): 36 mg, 60%; colourless, viscous oil. 1H NMR (300 MHz,
yl)acetate (5, R1 = Me; R2 = R3 = H; R4 = Ph; R5 = CO2Me):
CDCl3, 25 °C): δ = 2.01 (s, 3 H), 2.26 (s, 3 H), 2.52 (dd, J = 15.2,
4.3 Hz, 1 H), 2.72 (dd, J = 15.2, 8.6 Hz, 1 H), 3.59 (d, J = 19.2 Hz,
27.5 mg, 54%; yellow, viscous oil. 1H NMR (300 MHz, CDCl3,
3164
www.eurjoc.org
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2009, 3161–3166